Polymer-based materials category

HYPUCEM
The project is intended to set-up a new-technology-driven business for introducing a recently patented polyurethane-cement hybrid foam into the building market. The idea is to set-up a business in which the R&D as well as the designing capabilities of the core team are used to transfer innovations from materials and processes technologies to the field of construction, which is more and more demanding in terms of technical requirements (functional, energetic and structural), costs, and application time. This will be achieved by introducing a new material whose properties can be tailored to different applications. At the same time, the new materials/technologies are characterized by a strong capability of adapting to existing materials/technologies with the aim of improving the energetic, structural and functional properties of walls and floorings. The business will integrate the production of the new material with the new ways of designing structural and architectural parts of buildings. In fact, the possibility of optimizing the energetic, structural and functional properties of the new material, will allow the design of building elements with shapes and properties tailored to specific needs. Both the production of the new material and the engineering design will be part of the new business.

Nozzles & Needles
Nozzles & Needles® (NnN) has an attractive offer for its investors - an opportunity to commercialize its nano dispensing technology to semiconductor packaging and cosmetics. This is in addition to the already existing market for nano dispensing in trauma free therapeutics. NnN® targets the niche in polymer applications - advanced systems for high density semiconductor packaging, skin rejuvenation for the cosmetics industry and therapeutics of large molecule drugs that have restricted delivery mechanisms. NnN® is well positioned by way of technology to entirely disrupt the way these applications are handled today and foresees a rapid spread of its products to the targeted markets of the world. With an experienced yet dynamic management team, investors can enjoy the success of a creatively built company on a fast track with a sustainable and pro-investor business model.
With the initial capital requirement of EURO 860,000, the company is expected to show a triple digit growth over the first 5 years with an 8X return on investment.

Silvertech
Textile sector in Italy has an ancient tradition, driven by the fashion leading industry. However, such leadership has not been supported by relevant research and innovation in this field in the last 20 years. Here we present the results of five years of research for the production of a novel engineered textiles with unique antibacterial properties, for a number of applications, based both on natural and synthetic fibers.

So
'So' is a range of products for the regeneration of tissues which have been damaged by either disease or trauma. The products' characteristics respond to the demands of both clinical and veterinary surgery for highly performing and cost- effective biodegradable materials for bone and skin regeneration (e.g. dental and cranio-facial surgery and wound care). The products are based on novel natural, biodegradable and bioactive polymeric materials derived from soybean which are protected by the patent application PCT/GB01/03464. The business proposition is to establish a vibrant spin-off company driving the exploitation of the products by: (i) Their scaled-up production and validation at clinical level (ii) Their regulatory approval (iii) Their commercial exploitation by pursuing licensing and alliances with major companies The project aims at penetrating the worldwide market for biocompatible materials that is valued at US$28.7 billion in 2006 and it is forecast to be worth US$31.1 billion in 2007. The market is further projected to amount to US$ 39.1 billion in 2010, corresponding to a compound annual growth rate (CAGR) of 7.8% over the period 2000-2010. More specifically, So products have the potential of entering the global market for bone fillers for dental procedures that is estimated to be worth > $855 million a year (Biomet.com) and growing at a rate of 10-15%. Similarly, the technology will aim at the wound healing market that is projected to be worth in excess of $1 billion dollars by 2010. So team includes members with long-standing experience in the development and commercial exploitation of biomedical polymeric materials